rs119476044
Variant summary
Our verdict is Likely pathogenic. Variant got 6 ACMG points: 6P and 0B. PM2PM5PP3_Moderate
The NM_022051.3(EGLN1):c.1112G>C(p.Arg371Pro) variant causes a missense change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar. Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R371H) has been classified as Pathogenic.
Frequency
Consequence
NM_022051.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_pathogenic. Variant got 6 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
EGLN1 | NM_022051.3 | c.1112G>C | p.Arg371Pro | missense_variant | Exon 3 of 5 | ENST00000366641.4 | NP_071334.1 | |
EGLN1 | NM_001377260.1 | c.1112G>C | p.Arg371Pro | missense_variant | Exon 3 of 4 | NP_001364189.1 | ||
EGLN1 | NM_001377261.1 | c.1012-2962G>C | intron_variant | Intron 2 of 3 | NP_001364190.1 | |||
EGLN1 | XM_024447734.2 | c.1012-2962G>C | intron_variant | Intron 2 of 2 | XP_024303502.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
EGLN1 | ENST00000366641.4 | c.1112G>C | p.Arg371Pro | missense_variant | Exon 3 of 5 | 1 | NM_022051.3 | ENSP00000355601.3 | ||
ENSG00000287856 | ENST00000662216.1 | c.251G>C | p.Arg84Pro | missense_variant | Exon 5 of 7 | ENSP00000499467.1 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Cov.: 32
GnomAD4 genome Cov.: 32
ClinVar
Not reported inComputational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
No publications associated with this variant yet.